North central cancer treatment group (NCCTG) N0537: Phase II trial of vegf-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane
Kostandinos Sideras, Amylou C. Dueck, Timothy J. Hobday, Kendrith M. Rowland, Jacob B. Allred, Donald W. Northfelt, Wilma L. Lingle, Robert J. Behrens, Tom R. Fitch, Daniel A. Nikcevich, Edith A. Perez
Dive into the research topics of 'North central cancer treatment group (NCCTG) N0537: Phase II trial of vegf-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane'. Together they form a unique fingerprint.